Nordoxepin
Clinical data | |
---|---|
Other names | N-Desmethyldoxepin; Desmethyldoxepin; Demethyldoxepin; Monodesmethyldoxepin |
Pharmacokinetic data | |
Elimination half-life | 31 hours[1] |
Identifiers | |
| |
JSmol) | |
| |
|
Nordoxepin, also known as N-desmethyldoxepin, is an organic compound. A colorless solid, it attracted attention as the major active metabolite of the tricyclic antidepressant (TCA) doxepin (Sinequan).[2] It has been found to play a significant role in the antidepressant effects of doxepin.[3]
Nordoxepin is a
pharmaceutical doxepin is supplied in an approximate 85:15 ratio mixture of (E)- and (Z)-stereoisomers and plasma concentrations of doxepin remain roughly the same as this ratio with treatment, plasma levels of the (E)- and (Z)-stereoisomers of nordoxepin, due to stereoselective metabolism of doxepin by cytochrome P450 enzymes, are approximately 1:1.[2]
Nordoxepin is
Nordoxepin is formed from doxepin mainly by
elimination half-life of nordoxepin is approximately 31 hours, which is almost twice that of doxepin (mean 17 hours).[1]
See also
References
- ^ a b "Sinepin Capsules 25mg - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Marlborough Pharmaceuticals Ltd. 22 September 2011. Retrieved 3 December 2013.
- ^ ISBN 978-1-60913-345-0.
- ^ S2CID 41765748.
- S2CID 26739281.
- ^ ISBN 978-0-471-95052-3.
- ^ ISBN 978-3-527-64632-6.
- ISBN 978-1-58562-309-9.
- S2CID 8089917.